Press Release

back to browse more Press Release

Amyris & NIKKOL GROUP Complete Formation of Joint Venture Under Aprinnova Global Company Name

Print Form
Published by Amyris, Inc. Mar 3, 2017

EMERYVILLE, Calif., March 9, 2017 — Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced it has completed the formation of a previously announced joint venture with NIKKOL GROUP (“NIKKOL”), a leading Japanese cosmetic specialty chemical provider. The 50-50 joint venture will now operate globally under the brand name Aprinnova with the goal of continuing to develop and make available sustainable cosmetic ingredient solutions for responsible brands worldwide.

“We are delighted with the rapid progress we’ve made since initially announcing plans to establish the joint venture just a few weeks ago with our partner, NIKKOL,” said John Melo, Amyris President and CEO. “Aprinnova will continue its mission of providing innovative renewable cosmetic ingredients to the world’s finest brands and with NIKKOL’s support achieve further growth and market penetration.”

“As leading cosmetic brands further adopt renewable ingredients in response to consumer demand and to support their reputation for innovation, Aprinnova will continue to be a leading supply source for them,” said Caroline Hadfield, Senior Vice President of Personal Care at Amyris. “With the product development resources provided by NIKKOL and Amyris’s ability to create disruptive, high-performance products, Aprinnova will be a force for innovation in the cosmetic market.”

“We are pleased to have joined forces with Amyris for continued success in the markets we serve,” said Shizuo Ukaji, President and CEO of Nikko Chemicals Co., Ltd. in NIKKOL. “Our long-term relationship has enabled us to move quickly in completing formation of the joint venture and this relationship will serve us well in serving our customers and growing Aprinnova’s presence worldwide.”

Products in the Aprinnova joint venture include Neossance® Squalane and Neossance® Hemisqualane, which the joint venture will sell through its existing distribution channels in the US, EU, LATAM and Korea markets. Nikko will continue to sell its “Sugar Squalane” brand of emollients in Japan, China and Southeast Asia.

These products will continue to be manufactured at an existing facility in Leland, NC, held in the joint venture, which has been producing high-quality squalane since 2012. With this now wholly owned, vertically integrated manufacturing facility the joint venture will be able to fully leverage the quality its products are known for as a competitive advantage and a means to support the exacting requirements of leading brands.

Aprinnova will be exhibiting at the in-cosmetics tradeshow at booth MM40 in London April 4-6, 2017.  For more information about Aprinnova please visit www.aprinnova.com

About Amyris

Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company is delivering its No Compromise® products across a number of markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, and pharmaceuticals and nutraceuticals. More information about the company is available at www.amyris.com.

 

About NIKKOL GROUP

NIKKOL GROUP (“NIKKOL”) is a specialty chemical company known as one of the world’s leaders in the cosmetic ingredient industry. NIKKOL includes seven core companies for sales, R&D, manufacturing, safety and efficacy evaluation based on colloid chemical and skin science in Japan and overseas. NIKKOL has focused its business on the core strategy “Green, Clean, Sustainable” to achieve its business success. With 70 years’ experience and the concept of “One-Stop Services”, NIKKOL has been supporting its customers through variety of NIKKOL brand products, innovative formulation, tailor-made consultation, and rigorous safety and efficacy evaluation. More information about the company is available at www.nikkol.co.jp/en/.

 

 

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as the expected growth of and market penetration by Aprinnova, anticipated further adoption by cosmetic brands of renewable ingredients, and Aprinnova’s expected position as a leading supply source for cosmetic brands and a force for innovation in the cosmetic market) that involve risks and uncertainties. These statements are based on management’s current expectations and actual results and future events may differ materially due to risks and uncertainties, including risks related to manufacturing capacity, delays or failures in development, production and commercialization of products, liquidity and ability to fund capital expenditures, Amyris’s reliance on third parties to achieve its goals, and other risks detailed in the “Risk Factors” section of Amyris’s quarterly report on Form 10-Q filed on November 9, 2016. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

 

Amyris, the Amyris logo and Neossance are trademarks or registered trademarks of Amyris, Inc. All other trademarks are the property of their respective owners.

 

Contact:

Peter DeNardo

Director, Investor Relations and Corporate Communications

Amyris, Inc.

+1 (510) 740-7481

investor@amyris.com

pr@amyris.com

 

Privacy Policy Copyright © Amyris 2015 All Rights Reserved